---

Background: Chlamydia trachomatis infection is a sexually transmitted disease that its majority infections are asymptomatic and can cause infertility. So, determining its frequency and prevalent genotypes in each zone is necessary to provide clues for clinicians and also to prevent or minimize its complications. The aim of this study was determining the prevalence of   C. trachomatis and related genotypes in infertile women and relation with type of infertility.
Methods: For this purpose, a primary screening based on amplification of cryptic plasmid gene was done on endocervical samples obtained from infertile women referring to two infertility treatment clinics. Genotyping of positive samples was done based on PCR-RFLP of omp1 gene and then DNA digestion with Hpa II, Hinf I and Alu I restriction enzymes. The association of infection with age, abortion and primary and secondary infertility was analyzed by statistical analysis.
Results: As a result of this study, the frequency of C. trachomatis infection in 180 endocervical samples was 10.5 % in infertile women. The PCR-RFLP analysis results showed that E, F and D genotypes are prevalent in this population. There was a significant association between infection and abortion among patients with primary and secondary infertility.
Conclusions: Finally, based on the obtained results it can be concluded that C. trachomatis infection is prevalent in infertile women especially in secondary infertility.  So, it must be regarded in preventive care and control program hence its diagnosis and treatment can reduce infertility rate among women.

---

Introduction: Growth hormone is a non-glycosylated polypeptide strand of the pituitary glands of all vertebrates that has a wide range of biological activities and considering the importance of this hormone and its importance and diverse therapeutic applications in medicine, its recombinant production can be of great importance. In recent decades, protein engineering and genetic engineering have resulted in a high level of expression and production of this protein in a variety of hosts, including Escherichia coli bacteria using new techniques and methodes, hormone purification and assay are carried out easily. Therefore, the aim of this review was to investigate the production of recombinant human growth hormone (rhGH) and future challenges.
Conclusion: One of the problems of the expression and purification of the human growth hormone may involve that maybe noted the production of inclusion bodies in the expression of recombinant proteins in the cell cytoplasm, the contamination caused by host proteins, low protein recovery from these inclusion bodies, low protein secretion into the Periplasmic space, high cost of production, especially in Purification stage and so on. Due to the lack of need for glycosylated hormone and high efficiency and simplicity of work, bacterial systems, especially Escherichia coli, are the most economical and effective systems for the expression of heterologous proteins. The hormone purification stage is usually the most costly process. Therefore, an optimal design for achieving the highest target protein recovery with the elimination of all contamination from the final product and reducing the purification step is required.